[From platelet functions to therapy].
Inserm U698, hôpital Bichat, 46, rue Henri-Huchard, 75877 Paris cedex 18, France. mjandrot@bichat.inserm.fr
M
M
Jandrot-Perrus
P
P
Nurden
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000097:blood / Q000188:drug therapy*; D001791:Blood Platelet Disorders / Q000097:blood / Q000188:drug therapy*; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism*; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use
D020533:Angiogenesis Inhibitors; D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors